As part of its executive transition plan, SOPHiA Genetics announced the promotion of Ross Muken to Chief Executive Officer (CEO), effective July 1, 2026, succeeding Jurgi Camblong, co-founder and CEO. Ross, who currently serves as Presiden...
BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific disc...
ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced...
BOSTON and ROLLE, Switzerland, Oct. 16, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates ...
SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision m...
BOSTON, Sept. 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB &...
The Top100 Swiss Startup Ranking showcases the 100 Swiss startups with the most significant potential. Each year, a jury of 100 startup investors selects the most promising companies that are no older than five years after incorporation. W...
BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with Astra...
In the ever-evolving landscape of cancer diagnostics, a quiet revolution is underway. Liquid biopsy testing is emerging as a game-changer, offering a less invasive, more efficient way to monitor and treat cancer. At the forefront of this tr...
BOSTON and ROLLE, Switzerland, April 29, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today announced the expansion of its ongoing collaboration...
In the bustling landscape of modern entrepreneurship and healthcare, artificial intelligence (AI) is the silent engine driving transformation. From chatbots that guide budding entrepreneurs to sophisticated platforms analyzing genomic data,...
BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic p...
Launch of new application enables global access to highly recognized solid tumor profiling assay
BOSTON and ROLLE, Switzerland, Nov. 21, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in dat...
SOPHiA GENETICS and GENOMENON
The companies expand partnership to enhance genetic variant interpretation for cancers and rare diseases
BOSTON and ROLLE, Switzerland , Nov. 6, 2024 /PRNewswire-PRWeb/ -- SOPHiA GENETICS (Nasdaq: SOPH), a clou...
Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most benefit from combination immunotherapy
BOSTON and ROLLE, Switzerland, Sept. 14, 2024 /PRNewswire/ -- SOP...
Research presented will include the applications of new diagnostic tools and machine learning multimodal signatures in clinical trials
BOSTON and ROLLE, Switzerland, Sept. 12, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-nat...
The global collective intelligence network aims to accelerate precision oncology research and care
BOSTON and ROLLE, Switzerland, Sept. 12, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company an...
In the realm of cancer diagnostics, innovation is the lifeblood. Two recent collaborations highlight a seismic shift in how we approach cancer detection and treatment. SOPHiA GENETICS, a leader in data-driven medicine, is at the forefront o...
The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months
BOSTON and ROLLE, Switzerland, Sept. 10, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare tec...
The companies share how their collaboration enables clinical trial enrollment for a novel cancer therapy for oncogene amplified cancers in development by Boundless Bio
BOSTON and ROLLE, Switzerland, Sept. 5, 2024 /PRNewswire/ -- SOPHiA GENE...
Another of Odne’s products has received clearance from the U.S. Food & Drug Administration. Odne Clean is an endodontic debridement device, offering a novel approach to root canal disinfection, simplifying and accelerating the process....
Regulatory milestone validates the SOPHiA DDM™ Platform as diagnostic tool in select markets
BOSTON and ROLLE, Switzerland, Aug. 14, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a glo...
Zendesk has announced the appointment of Lila Tretikov to its Board of Directors. Tretikov, who currently serves as Partner and Head of AI Strategy at New Enterprise Associates (NEA), was previously the Deputy Chief Technology Officer at Mi...
In the world of healthcare, precision is paramount. SOPHiA GENETICS is at the forefront of this revolution. The company is reshaping how we understand and treat cancer. With cutting-edge technology, they are making waves in blood cancer res...
The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers
BOSTON and ROLLE, Switzerland, July 29, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company an...
OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™
BOSTON and ROLLE, Switzerland, July 24, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader...
The diagnostics company has implemented the SOPHiA DDM™ Platform to enhance its solid tumor testing
BOSTON and ROLLE, Switzerland, July 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and...
Novel application supports measurable residual disease (MRD) testing to help monitor cancer and stay ahead of relapse
BOSTON and ROLLE, Switzerland, June 24, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare tec...
The Hospital will use SOPHiA DDM™ to enhance its testing and research of blood cancers
BOSTON and ROLLE, Switzerland, June 13, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in...
New collective intelligence network to enable the most advanced research in oncology in support of precision medicine
BOSTON and ROLLE, Switzerland, May 30, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare tech...
In collaboration with Microsoft and NVIDIA, SOPHiA GENETICS is developing a comprehensive whole genome analytical solution
BOSTON and ROLLE, Switzerland, May 29, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare...
The hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™ Platform
BOSTON and ROLLE, Switzerland, May 20, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a...
The SOPHiA DDM™ Platform will help broaden the hospital's cancer testing and diagnostic capabilities
BOSTON and ROLLE, Switzerland, May 16, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in...
With currently 463 core genomics customers, SOPHiA GENETICS continues to see strong adoption of its SOPHiA DDM platform in clinical markets globally. In the first quarter, SOPHiA GENETICS announced partnerships with several prominent healt...
Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa
BOSTON and ROLLE, Switzerland, April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healt...
The companies will join forces to advance the use of precision medicine on a global scale
BOSTON and ROLLE, Switzerland, April 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space a...
Presented by Microsoft
Microsoft’s announcements about brand-new collaborations with long-standing partner Nvidia put the company at the forefront of this year’s Nvidia GTC AI conference in San Jose, March 18 – 21.
The week’s round of AI in...
Microsoft is deepening its partnership with NVIDIA to harness the power of generative AI, cloud computing, and accelerated computing for the healthcare and life sciences sectors. This collaboration aims to merge Microsoft Azure's extensive ...
New Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer Research
BOSTON and ROLLE, Switzerland, March 15, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a l...
SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain
BOSTON and ROLLE, Switzerland and MADRID, Feb. 7, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native...
The company announced Bioma4me has implemented SOPHiA DDM to support its rare disorder testing capabilities
SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced that Bioma4...
The partnership will drive testing and research for blood cancers and solid tumors
In 2018, a report from the Institute of Health Metrics and Evaluation found that India ranked tenth among the countries with the lowest rate of cancer incide...
SOPHiA GENETICS technology helps advance cancer research across India
SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge genomic solutions for breakthroughs in personalized cancer care in India
BOSTON and ROLLE, Swit...
The SOPHiA DDM™ Platform used by IHG PAS to advance its research of male infertility
BOSTON and ROLLE, Switzerland, Nov. 17, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven me...
The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science
BOSTON and ROLLE, Switzerland, Oct. 18, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cate...
SOPHiA GENETICS, a cloud-native software company and the leader in data-driven medicine, celebrates with longstanding partner, Dasa, the largest integrated healthcare network in Brazil, as it reaches a milestone of 2,000 samples analyzed fo...
SOPHiA GENETICS supports The University of Maryland Medical Center to advance their rare disease research
SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced that the Univ...
SOPHiA DDM for Hereditary Cancers Enables Krsnaa Diagnostics to Expand its NGS Offerings
SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced that Krsnaa Diagnostics, India...
The New Assay Will Screen Patients for Clinical Trials and Help Increase Data Analysis for Clinical Researchers
SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced that Ac...
Collaboration provides a solution for a more in-depth analysis of cancer biomarkers
SOPHiA GENETICS , a cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with Agilent to offer a comp...
SOPHiA GENETICS, a cloud-native software company and the leader in data-driven medicine, announced the University of Arkansas for Medical Sciences (UAMS), based in Little Rock, AR, will use SOPHiA GENETICS’ platform to support their clinica...
The New Solution uses SOPHiA DDM and aims to Benefit Cancer Research, Clinical Studies and Patient Care
SOPHiA GENETICS, a cloud-native software company in the healthcare space, announced that Synergy Oncology, part of Synergy Laboratories,...
SOPHiA GENETICS SA, the creator of a leading cloud-native global data-sharing network and health analytics platform, is partnering with AstraZeneca to apply their multimodal technology and expertise to the biopharmaceutical company’s oncolo...
SOPHiA GENETICS SA (Nasdaq: SOPH), today announced that the Company has published its first Environmental, Social and Governance Impact Summary. The ESG Impact Summary highlights the Company’s policies, ongoing practices, and recent initiat...
19 dynamic startups take the stage at the Startup Champions Seed Night 2022 06.05.2022 13:43, Tracy Woodley linkedIn facebook twitter instagram youtube -->
The Startup Champions Seed Night is an annual startup presentation event that bri...
Join today's leading executives online at the Data Summit on March 9th. Register here.
Let the OSS Enterprise newsletter guide your open source journey! Sign up here.
Starburst, the company behind the open source Presto-based SQL query engi...
We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Let the OSS Enterprise newsletter guide your open...
BOSTON and LAUSANNE, Switzerland, Jan. 10, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their lead...
We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Let the OSS Enterprise newsletter guide your open...
Hear from CIOs, CTOs, and other C-level and senior execs on data and AI strategies at the Future of Work Summit this January 12, 2022. Learn more
Let the OSS Enterprise newsletter guide your open source journey! Sign up here.
As privacy reg...
New bioinformatic workflow advances analysis capabilities for whole exome assessment and interpretation
BOSTON and LAUSANNE, Switzerland, Nov. 1, 2021 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling a...
SOPHiA Clinical Exome Solution v3 offers a streamlined end-to-end workflow to facilitate the assessment of challenging Mendelian disorders
BOSTON and LAUSANNE, Switzerland, Oct. 13, 2021 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), th...
SOPHiA GENETICS goes public at NASDAQ raising USD 234 million 28.07.2021 17:49, Guillaume Tinsel linkedIn facebook twitter instagram youtube -->
Lausanne-based SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharin...
BOSTON and LAUSANNE, Switzerland, July 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the closing of it...
SOPHiA GENETICS, NASDAQ ($SOPH), valued at $1.14 billion, is one of the largest European Unicorns to go public. The Lausanne based company sold 13 million shares for $18 per share, the midpoint of its range. J.P. Morgan, Morgan Stanley, Cow...
BOSTON, LAUSANNE, Switzerland and TOKYO, March 25, 2021 /PRNewswire/ -- SOPHiA GENETICS SA ("SOPHiA GENETICS"), pioneer in Data-Driven Medicine, and Hitachi, Ltd. (TSE: 6501, "Hitachi") today announced they have entered ...
Gamaya, a leader in remote sensing for agriculture, has appointed Igor Ivanov as its new CEO, succeeding Mathieu Hagen, who joined in February 2020 with the mission to transform the company and prepare it for growth. Ivanov previously held ...
Scailyte uses single-cell technologies and AI to discover biomarkers for diseases in oncology and immunology. The company’s proprietary single-cell data analysis platform, ScaiVision delivers best-in-class performance for supervised pattern...
Tomahawk.VC invests in teams and founders with a 'global-first' approach. Since its launch in April 2020, the firm has concluded four investments across B2B SaaS and Decentralized Finance with teams in Germany and Switzerland. To further su...
Image: Sophia Genetics
A Boston healthtech giant just received $110 million in funding.
On Thursday, SOPHiA GENETICS announced it plans to spend the Series F round on driving adoption of its platform across the United States and Asia, as we...
4 Shares Email Facebook Twitter LinkedIn
By Robin Wauters, co-founder and editor-in-chief of Tech.eu, with previous stints at The Next Web and TechCrunch under his belt.
Last week, our research team tracked 69 funding deals worth about 1.4 ...
SOPHiA GENETICS raises USD $110 million to enter into the next stage of its expansion 02.10.2020 09:40, Isabelle Mitchell linkedIn facebook twitter instagram youtube -->
SOPHiA GENETICS, global leader in data-driven medicine, announced t...
Sophia Genetics has secured $110 million in a Series F co-led by aMoon and Hitachi Ventures, with support from Endeavour Vision, Swisscom Ventures and Alychlo. The Swiss startup is the developer of an AI-based medical data platform that hel...
SOPHiA GENETICS, the shoutily and poorly capitalized-named startup that’s combining machine learning tools for medical imaging and genetic sequencing to come up with a more holistic view of diseases for better patient care, has raised $110 ...
With the closure of its sixth venture capital round, the Swiss health data firm Sophia Genetics has added another $110 million to its coffers as it looks to expand further into the U.S. and Asia.
Sponsored by Agilent Technologies
How would ...
Data-driven medicine leader SOPHiA GENETICS announces a $110M oversubscribed fundraising round, led by aMoon Fund and Hitachi Ventures, alongside new and existing investors.
Having established the world’s largest Data-Driven Medicine commu...
SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the closing of a $110 million financing round to enter into the next stage of its expansion, with a focus on supporting the growing clinical and biopharma demand for Da...
SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the closing of a $110 million financing round to enter into the next stage of its expansion, with a focus on supporting the growing clinical and biopharma demand for Da...
This Series F round was led by aMoon, a leading health-tech & life sciences venture fund based in Israel, and Hitachi Ventures, a venture arm of Japanese Hitachi Group. The company also received the trust of prime financial institutions...
With the closure of its sixth venture capital round, the Swiss health data firm Sophia Genetics has added another $110 million to its coffers as it looks to expand further into the U.S. and Asia.
The company’s series F financing was led by ...
Artificial intelligence or machine intelligence refers to the intelligence shown by machines in a manner similar to that of humans. AI is trending across the globe and why not, since it has been useful in developing solutions across industr...
Forbes has nominated 30 promising startups from the DACH region whose solutions leverage artificial intelligence (AI) in the areas of text and speech analysis, healthcare and medicine, transport, software development, travel, space, logisti...
The world is battling against the Coronavirus as different players from medical workers to government members struggle to understand the virus and develop an immunization program for it, or to find the appropriate medication to treat patien...
